Zerila Therapeutics News | Page 2 of 7 | Cannabiz

Company news: Neurotech; Emyria; Cann Group; Incannex; Creso Pharma; Greenfern; Zelira; Organic Genetics

by Martin Lane November 24, 2022April 29, 2024

Neurotech International Neurotech has received Human Research Ethics Committee approval and TGA clearance to begin a […]

Zelira

Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare

by Martin Lane September 22, 2022April 29, 2024

Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience

by Steve Jones and Martin Lane September 1, 2022April 29, 2024

‘We needed an Aussie operation,’ says Creso boss, as expansion talks begin with Health House International

by Steve Jones August 4, 2022April 29, 2024

Creso Pharma inks A$4.6m deal to buy Health House International

by Martin Lane July 31, 2022April 29, 2024

Company news: LGP; Humacology; TSNG; Creso Pharma; ECS Botanics; Zelira; Cannasouth

by Martin Lane July 14, 2022April 29, 2024

Zelira

Zelira’s ‘multiple shots on goal’ will drive profitability, says global CEO

by Steve Jones June 30, 2022April 29, 2024

Zelira’s Health House acquisition called off

by Martin Lane and Steve Jones June 22, 2022April 29, 2024

Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira

by Martin Lane June 8, 2022April 29, 2024

Company news: Helius; Greenfern Industries; Zelira; Creso Pharma; Emyria; Roto-Gro International

by Martin Lane June 2, 2022April 29, 2024